MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA • CA55293N1096
38.39 CAD
+0.55 (+1.45%)
Last: Feb 24, 2026, 07:00 PM
We assign a fundamental rating of 5 out of 10 to MDA. MDA was compared to 13 industry peers in the Aerospace & Defense industry. MDA has an average financial health and profitability rating. MDA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make MDA suitable for growth investing!
1. Profitability
1.1 Basic Checks
- MDA had positive earnings in the past year.
- MDA had a positive operating cash flow in the past year.
- Of the past 5 years MDA 4 years were profitable.
- In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
- MDA has a worse Return On Assets (3.15%) than 69.23% of its industry peers.
- MDA has a better Return On Equity (8.24%) than 84.62% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 5.12%, MDA is doing worse than 61.54% of the companies in the same industry.
- MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 9.34%.
- The last Return On Invested Capital (5.12%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 7.40%, MDA is in line with its industry, outperforming 46.15% of the companies in the same industry.
- MDA's Profit Margin has improved in the last couple of years.
- MDA has a worse Operating Margin (9.86%) than 61.54% of its industry peers.
- In the last couple of years the Operating Margin of MDA has grown nicely.
- Looking at the Gross Margin, with a value of 24.62%, MDA is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
- MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- MDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for MDA has been increased compared to 1 year ago.
- The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
- MDA has an Altman-Z score of 1.79. This is a bad value and indicates that MDA is not financially healthy and even has some risk of bankruptcy.
- MDA has a Altman-Z score of 1.79. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
- The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
- MDA has a better Debt to FCF ratio (0.92) than 100.00% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
- MDA has a Debt to Equity ratio of 0.31. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.79 |
ROIC/WACC0.57
WACC9.04%
2.3 Liquidity
- MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDA has a Current ratio of 0.55. This is amonst the worse of the industry: MDA underperforms 84.62% of its industry peers.
- MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDA's Quick ratio of 0.54 is in line compared to the rest of the industry. MDA outperforms 53.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 98.25% over the past year.
- MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
- Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 57.77%.
- Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
- Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.72% on average per year.
- The Revenue is expected to grow by 23.84% on average over the next years. This is a very strong growth
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- MDA is valuated quite expensively with a Price/Earnings ratio of 33.97.
- Compared to the rest of the industry, the Price/Earnings ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 69.23% of the companies listed in the same industry.
- MDA's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.98.
- Based on the Price/Forward Earnings ratio of 24.84, the valuation of MDA can be described as rather expensive.
- The rest of the industry has a similar Price/Forward Earnings ratio as MDA.
- The average S&P500 Price/Forward Earnings ratio is at 28.01. MDA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.97 | ||
| Fwd PE | 24.84 |
4.2 Price Multiples
- 69.23% of the companies in the same industry are cheaper than MDA, based on the Enterprise Value to EBITDA ratio.
- MDA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDA is cheaper than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.4 | ||
| EV/EBITDA | 19.21 |
4.3 Compensation for Growth
- MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.72% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y48.58%
EPS Next 3Y35.72%
5. Dividend
5.1 Amount
- No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (2/24/2026, 7:00:00 PM)
38.39
+0.55 (+1.45%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.85B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts80
Price Target46.98 (22.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)15.3%
PT rev (3m)14.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.97 | ||
| Fwd PE | 24.84 | ||
| P/S | 3.28 | ||
| P/FCF | 10.4 | ||
| P/OCF | 6.59 | ||
| P/B | 3.65 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.21 |
EPS(TTM)1.13
EY2.94%
EPS(NY)1.55
Fwd EY4.03%
FCF(TTM)3.69
FCFY9.62%
OCF(TTM)5.82
OCFY15.17%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.32
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.79 |
F-Score6
WACC9.04%
ROIC/WACC0.57
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 5 / 10 to MDA.CA.
Can you provide the valuation status for MDA SPACE LTD?
ChartMill assigns a valuation rating of 4 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.
What is the financial health of MDA SPACE LTD (MDA.CA) stock?
The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.
What is the earnings growth outlook for MDA SPACE LTD?
The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.